[HTML][HTML] Development and prevalence of castration-resistant prostate cancer subtypes
JE Vellky, WA Ricke - Neoplasia, 2020 - Elsevier
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
Development and prevalence of castration-resistant prostate cancer subtypes
JE Vellky, WA Ricke - Neoplasia (New York, NY), 2020 - pubmed.ncbi.nlm.nih.gov
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
Development and prevalence of castration-resistant prostate cancer subtypes.
JE Vellky, WA Ricke - Neoplasia (New York, NY), 2020 - europepmc.org
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
Development and prevalence of castration-resistant prostate cancer subtypes
JE Vellky, WA Ricke - Neoplasia, 2020 - hero.epa.gov
BACKGROUND: Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
[引用][C] Development and prevalence of castration-resistant prostate cancer subtypes
JE Vellky, WA Ricke - Neoplasia, 2020 - cir.nii.ac.jp
Development and prevalence of castration-resistant prostate cancer subtypes | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …
[HTML][HTML] Development and prevalence of castration-resistant prostate cancer subtypes
JE Vellky, WA Ricke - Neoplasia (New York, NY), 2020 - ncbi.nlm.nih.gov
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
Development and prevalence of castration-resistant prostate cancer subtypes.
JE Vellky, WA Ricke - Neoplasia (New York, NY), 2020 - europepmc.org
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …